https://www.selleckchem.com/peptide/apamin.html The coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, SARS-CoV-2, affects tissues from different body systems but mostly the respiratory system, and the damage evoked in the lungs may occasionally result in severe respiratory complications and eventually lead to death. Studies of human respiratory infections have been limited by the scarcity of functional models that mimic in vivo physiology and pathophysiology. In the last decades, organoid models have emerged as potential research tools due to the possibility of reproducing in vivo tissue in culture. Despite being studied for over one year, there is still no effective treatment against COVID-19, and investigations using pulmonary tissue and possible therapeutics are still very limited. Thus, human lung organoids can provide robust support to simulate SARS-CoV-2 infection and replication and aid in a better understanding of their effects in human tissue. The present review describes methodological aspects of different protocols to develop airway and alveoli organoids, which have a promising perspective to further investigate COVID-19.Exsolution is a promising technique to design metal nanoparticles for electrocatalysis and renewable energy. In this work, Ni-doped perovskites, (Pr0.5Ba0.5)1-x/2Mn1-x/2Nix/2O3-δ with x = 0, 0.05, 0.1, and 0.2 (S-PBMNx), were prepared to design exsolution systems as solid oxide fuel cell anodes and for catalysis applications. X-ray diffraction and transmission electron microscopy (TEM) analyses demonstrated that correlating A-site deficiency with Ni content can effectively induce exsolution of all Ni under H2 atmosphere at T ∼ 875 °C, yielding the reduced (exsolved) R-PBMNx materials. On heating the exsolution systems in air, metal incorporation in the oxide lattice did not occur; instead, the Ni nanoparticles oxidized to NiO on the layered perovskite surface. The lowest area-specific resistance (ASR) under wet 5% H2/N